Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Chlamydia influences local symptoms in IBD

Researchers in August's issue of the European Journal of Gastroenterology & Hepatology show that in Crohn's disease, inflamed tissue specimens contain more C. pneumonia DNA, and influences local clinical manifestations.

News image

fiogf49gjkf04

Chlamydia has been associated with autoimmune diseases.

However, a link between chlamydial infection and the etiopathogenesis of inflammatory bowel disease (IBD) remains controversial.

Dr Stefan Müller and colleagues assessed the relationship between chlamydial infection and IBD.

The team evaluated the association as evidenced by serological measurement and DNA analysis of mucosal biopsy specimens.

The sera of 78 patients with Crohn's disease, and 24 patients with ulcerative colitis were tested for anti-C. pneumonia.

The investigators also assessed 73 healthy family members, and 20 healthy controls for anti-C. pneumonia IgG titres.

C. pneumonia DNA was found in 27% in inflamed biopsy specimens of Crohn's patients
European Journal of Gastroenterology & Hepatology

A subgroup consisting of 13 ulcerative colitis and 39 Crohn's disease patients was screened for the presence of chlamydial DNA.

The patients were screened on 42 inflamed versus 30 non-inflamed biopsy specimens and for mutations of their NOD2/CARD15 gene.

The investigators found anti-C. pneumonia IgG antibodies in the sera of 41% of patients with Crohn's disease, and 46% of patients with ulcerative colitis.

The team observed that 48% of unaffected family members, and 45% unrelated healthy controls had anti-C pneumonia IgG antibodies in the sera.

The team noted that 35% of the control, 18% of Crohn's and 24% of ulcerative colitis biopsy specimens contained C. pneumonia DNA.

In Crohn's disease, however, C. pneumonia DNA was found in 27% in inflamed versus 8% of non-inflamed biopsy specimens.

The frequencies of NOD2/CARD15 mutations were 33% for Crohn's disease patients with C. pneumonia DNA.

The investigators found the genetic mutations in 47% for Crohn's disease patients without C. pneumonia DNA.

Dr Müller's team concludes, “We found no marked differences in respect to anti-C. pneumonia serum IgG or C. pneumonia DNA between healthy controls and patients with IBD.”

“However, in Crohn's disease patients, inflamed tissue specimens contained significantly more C. pneumonia DNA compared with biopsies from unaffected areas.”

“C. pneumonia is unlikely to be of pathogenic importance in IBD while it may still influence local clinical manifestations.”

Eur J Gastroenterol Hepatol 2006: 18(8): 889-94
20 July 2006

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us